NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" ...
Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.95. According to InvestingPro analysis, the company, now valued at $4.69 billion, shows signs of being slightly ...
Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s ...
Zacks.com on MSN7d
Reasons to Retain Inari Medical Stock in Your Portfolio for NowInari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...
In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other smid-cap stocks. As the name suggests, smid-cap stocks have a valuation between $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback